United states securities and exchange commission

Table of Contents
29
Our Employees
As of December 31, 2017, we had approximately 7,300 employees worldwide.
Our Executive Officers (as of February 1, 2018)
Officer
Current Position
Age
Year
Joined
Biogen
Michel Vounatsos
Chief Executive Officer
56
2016
Susan H. Alexander
Executive Vice President, Chief Legal, Corporate Services and
Secretary
61
2006
Jeffrey D. Capello
Executive Vice President and Chief Financial Officer
53
2017
Gregory F. Covino
Vice President, Finance and Chief Accounting Officer
52
2012
Michael D. Ehlers, M.D., Ph.D.
Executive Vice President, Research and Development
49
2016
Ginger Gregory, Ph.D.
Executive Vice President and Chief Human Resources Officer
50
2017
Chirfi Guindo
Executive Vice President and Head of Global Marketing, Market
Access and Customer Innovation
52
2017
Paul McKenzie, Ph.D.
Executive Vice President, Pharmaceutical Operations and
Technology
52
2016
Alfred W. Sandrock, Jr., M.D., Ph.D.
Executive Vice President and Chief Medical Officer
60
1998
Michel Vounatsos
Experience
Mr. Vounatsos has served as our Chief Executive Officer since January 2017. Prior to that, from April 2016 to
December 2016, Mr. Vounatsos served as our Executive Vice President and Chief Commercial Officer. Prior to
joining Biogen, Mr. Vounatsos spent 20 years at Merck where he most recently served as President, Primary Care,
Customer Business Line. In this role, he led Merck’s global primary care business unit, a role which encompassed
Merck’s cardiology-metabolic, general medicine, women’s health and biosimilars groups and developed and
instituted a strategic framework for enhancing the company’s relationships with key constituents, including the
most significant providers, payors and retailers and the world’s largest governments. Mr. Vounatsos previously held
leadership positions across Europe and in China for Merck. Prior to that, Mr. Vounatsos held management
positions at Ciba-Geigy.
Education
Universite Victor Segalen, Bordeaux II, France, C.S.C.T. Certificate in Medicine
HEC School of Management - Paris, M.B.A.
Susan H. Alexander
Experience
Ms. Alexander has served as our Executive Vice President, Chief Legal, Corporate Services and Secretary since
March 2017. Prior to that, from December 2011 to March 2017, Ms. Alexander served as our Executive Vice
President, Chief Legal Officer and Secretary and from 2006 to December 2011, as our Executive Vice President,
General Counsel and Corporate Secretary. From 2003 to January 2006, Ms. Alexander served as the Senior Vice
President, General Counsel and Corporate Secretary of PAREXEL International Corporation, a biopharmaceutical
services company. From 2001 to 2003, Ms. Alexander served as General Counsel of IONA Technologies, a software
company. From 1995 to 2001, Ms. Alexander served as Counsel at Cabot Corporation, a specialty chemicals and
performance materials company. Prior to that, Ms. Alexander was a partner at the law firms of Hinckley, Allen &
Snyder and Fine & Ambrogne.
Public Company Boards
Board of Directors of Invacare Corporation, a medical and healthcare product company
Education
Wellesley College, B.A.
Boston University School of Law, J.D.

---

Table of Contents
30
Jeffrey D. Capello
Experience
Mr. Capello has served as our Executive Vice President and Chief Financial Officer since December 2017.  Prior to
that, Mr. Capello served as the Chief Financial Officer of Beacon Health Options, Inc., a behavioral health company,
with responsibility for finance, human resources, information technology, real estate and procurement, from October
2016 until November 2017. From July 2015 until September 2016, Mr. Capello was the founder and Chief
Executive Officer of Monomoy Advisors which focuses on helping companies drive shareholder value. From July
2014 until June 2015, Mr. Capello served as the Executive Vice President and Chief Financial Officer of Ortho-
Clinical Diagnostics, an in vitro diagnostics company that was acquired by the Carlyle Group from Johnson &
Johnson, with responsibility for global finance and business development. Prior to his role at Ortho-Clinical
Diagnostics, Mr. Capello served as Chief Financial Officer and Executive Vice President of Boston Scientific
Corporation, a medical device company, from March 2010 to December 2013. At Boston Scientific, Mr. Capello was
responsible for the worldwide management of Boston Scientific’s finance, information systems, business
development and corporate strategy functions. Mr. Capello joined Boston Scientific in June 2008 and served as
Senior Vice President and Chief Accounting Officer until March 2010. Prior to joining Boston Scientific, he was the
Senior Vice President and Chief Financial Officer with responsibilities for global finance and business development
at PerkinElmer, Inc., a life sciences tool company, from 2006 to 2008. Previously, he served as PerkinElmer’s Vice
President of Finance, Corporate Controller, Treasurer and Chief Accounting Officer from 2001 to 2006. Prior to his
tenure at PerkinElmer, Mr. Capello was a Partner at PricewaterhouseCoopers LLP, both in the United States and in
the Netherlands.
Public Company Boards
OvaScience, Inc., a biotechnology company
Flex Pharma, Inc., a biotechnology company
Education
University of Vermont, B.S. in Business Administration
Harvard Business School, M.B.A.
Gregory F. Covino
Experience
Mr. Covino has served as our Vice President and Chief Accounting Officer since April 2012. From June 2017 to
December 2017, Mr. Covino also served as our interim Principal Financial Officer. From March 2010 to April 2012,
Mr. Covino served at Boston Scientific Corporation, a medical device company, as Vice President, Corporate
Analysis and Control, having responsibility for the company's internal audit function, and as Vice President, Finance,
International from February 2008 to March 2010, having responsibility for the financial activities of the company's
international division. Prior to that, Mr. Covino held several finance positions at Hubbell Incorporated, an electrical
products company, including Vice President, Chief Accounting Officer and Controller from 2002 to January 2008,
Interim Chief Financial Officer from 2004 to 2005, and Director, Corporate Accounting from 1999 to 2002.
Education
Bryant University, B.S. in Business Administration

---